Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Soybean-derived SEB oral vaccine
- Development stage
- Preclinical
- Lead developer
- SoyMeds
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Administration
- Oral
01
Overview
Soybean-derived SEB oral vaccine is a recombinant protein subunit vaccine developed by SoyMeds for the prevention of Staphylococcal Enterotoxin B (SEB) intoxication, primarily for biodefense applications. The vaccine is produced using a proprietary platform that utilizes soybean seeds as an expression system for recombinant proteins. This technology enables the production of a stable, oral (mucosal) vaccine that does not require refrigeration. The vaccine is designed to induce both mucosal and systemic antibody responses that neutralize the SEB toxin. Preclinical studies in piglet models have demonstrated its ability to elicit these immune responses, suggesting potential for protecting against the toxic effects of SEB exposure.
- Other names
- Soybean-derived SEB vaccineSEB Oral VaccineSoybean-derived staphylococcal enterotoxin B oral vaccine
02
Targets
SEB (Staphylococcal enterotoxin B)
Beyond the preview
Go deeper on Soybean-derived SEB oral vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Soybean-derived SEB oral vaccine.